Furthermore, not only ATF6 but also IRE1 and PERK, the other two branches of the ER–UPR, have been shown to be activated in different ALS experimental models as well as in patient samples [31,36,37,38,39]. The gene discussed is ATF6; the disease is amyotrophic lateral sclerosis.